Latest Omeros Corporation Stories
-- PDE10 Target Engagement Continues to Increase with Well-Tolerated Doses -- SEATTLE, Feb.
-- Enrollment in Huntington's Phase 2 Trial Expected Soon -- SEATTLE, Feb. 5, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that the U.S.
-- Phase 2 Program Expected to Initiate this Quarter -- SEATTLE, Feb.
- Data expand potential indications both within schizophrenia and to other neuropsychiatric disorders - SEATTLE, Jan.
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.